FDA approves first direct-to-consumer glucose monitor | Cromos Pharma
Revolutionizing Diabetes Management: FDA Approves First Direct-to-Consumer Glucose Monitor The FDA has given the green light to the Dexcom Stelo Glucose Biosensor System, the first of its kind continuous glucose monitor (CGM) that will be available directly to consumers. Slated for release in summer 2024, this innovative device offers adults over 18 who do not rely on insulin a novel way to monitor their
Country Head for Türkiye | Cromos Pharma
Cromos Pharma’s new Country Head for Türkiye Cromos Pharma is delighted to introduce Seniz Sagol as our new Country Head for Türkiye. Seniz Sagol Tuysuz brings over 22 years of expertise in Clinical Operations, with a comprehensive background in Global Project Management, Country Management, and Line Management across diverse functions. A pharmacist by education, Seniz has held pivotal roles such as Head
Vlad Bogin at the J.P.Morgan Healthcare Conference 2024
Cromos Pharma’s umbrellas are a hit At the J.P. Morgan Healthcare Conference in San Francisco, the rainy weather made our umbrellas a practical addition for our clients.  It was a great experience, and we plan to continue offering thoughtful gifts to our partners and clients next year. Cromos Pharma proudly supports the Right2hope nonprofit platform, empowering patients to explore treatment options

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us